Literature DB >> 4061511

Microinvasive carcinoma of the vagina: a distinct clinical entity?

W A Peters, N B Kumar, G W Morley.   

Abstract

Six patients with superficially invasive squamous carcinoma of the vagina are described. All had less than 2.5 mm of invasion as measured from the surface, lacked involvement of the lymph-vascular spaces, and arose within a field of carcinoma in situ. Three of the six had previously been treated for carcinoma of the cervix. The patients with microinvasive carcinoma had a median age 10 years younger than that of patients with Stage I carcinoma of the vagina. Treatment of the six patients has been by partial or total vaginectomy. With follow-up of 51 to 172 months, there have been no recurrences. More experience is needed to define microinvasive squamous carcinoma of the vagina and to determine the optimal treatment for these lesions.

Entities:  

Mesh:

Year:  1985        PMID: 4061511     DOI: 10.1016/0002-9378(85)90462-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  [Interdisciplinary S2k guidelines on the diagnosis and treatment of vaginal carcinoma and its precursors-recommendations on surgical pathology for histopathological workup, diagnostics, and reporting].

Authors:  Lars-Christian Horn; Anne Kathrin Höhn; Monika Hampl; Grit Mehlhorn; Markus Follmann; Hans-Georg Schnürch
Journal:  Pathologe       Date:  2021-02       Impact factor: 1.011

2.  Comparison of laparoscopic peritoneal vaginoplasty and sigmoid colon vaginoplasty performed during radical surgery for primary vaginal carcinoma.

Authors:  Fengqiu Yao; Weidong Zhao; Gang Chen; Aijun Zhang; Fanglin Sun; Weiping Hu; Bin Ling
Journal:  World J Surg Oncol       Date:  2014-09-30       Impact factor: 2.754

3.  Laparoscopic upper vaginectomy for post-hysterectomy high risk vaginal intraepithelial neoplasia and superficially invasive vaginal carcinoma.

Authors:  Youn Jin Choi; Soo Young Hur; Jong Sup Park; Keun Ho Lee
Journal:  World J Surg Oncol       Date:  2013-06-03       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.